204 related articles for article (PubMed ID: 9853085)
1. [Phenotype-genotype relations in growth hormone insensitivity].
Savage MO; Woods KA; Clark AJ; Amselem S
Arch Pediatr; 1998; 5 Suppl 4():364S-370S. PubMed ID: 9853085
[TBL] [Abstract][Full Text] [Related]
2. Phenotype: genotype relationships in growth hormone insensitivity syndrome.
Woods KA; Dastot F; Preece MA; Clark AJ; Postel-Vinay MC; Chatelain PG; Ranke MB; Rosenfeld RG; Amselem S; Savage MO
J Clin Endocrinol Metab; 1997 Nov; 82(11):3529-35. PubMed ID: 9360502
[TBL] [Abstract][Full Text] [Related]
3. Relationship between phenotype and genotype in growth hormone insensitivity syndrome.
Woods KA; Clark AJ; Amselem S; Savage MO
Acta Paediatr Suppl; 1999 Feb; 88(428):158-62; discussion 163. PubMed ID: 10102073
[TBL] [Abstract][Full Text] [Related]
4. National Cooperative Growth Study substudy VI: the clinical utility of growth-hormone-binding protein, insulin-like growth factor I, and insulin-like growth factor-binding protein 3 measurements.
Attie KM; Julius JR; Stoppani C; Rundle AC
J Pediatr; 1997 Jul; 131(1 Pt 2):S56-60. PubMed ID: 9255230
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor binding protein-3 generation: an index of growth hormone insensitivity.
Thalange NK; Price DA; Gill MS; Whatmore AJ; Addison GM; Clayton PE
Pediatr Res; 1996 May; 39(5):849-55. PubMed ID: 8726240
[TBL] [Abstract][Full Text] [Related]
6. Partial growth-hormone insensitivity: the role of growth-hormone receptor mutations in idiopathic short stature.
Goddard AD; Dowd P; Chernausek S; Geffner M; Gertner J; Hintz R; Hopwood N; Kaplan S; Plotnick L; Rogol A; Rosenfield R; Saenger P; Mauras N; Hershkopf R; Angulo M; Attie K
J Pediatr; 1997 Jul; 131(1 Pt 2):S51-5. PubMed ID: 9255229
[TBL] [Abstract][Full Text] [Related]
7. Intronic mutation in the growth hormone (GH) receptor gene from a girl with Laron syndrome and extremely high serum GH binding protein: extended phenotypic study in a very large pedigree.
Silbergeld A; Dastot F; Klinger B; Kanety H; Eshet R; Amselem S; Laron Z
J Pediatr Endocrinol Metab; 1997; 10(3):265-74. PubMed ID: 9388817
[TBL] [Abstract][Full Text] [Related]
8. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.
Cotterill AM; Camacho-Hübner C; Duquesnoy P; Savage MO
Clin Endocrinol (Oxf); 1998 Jun; 48(6):719-24. PubMed ID: 9713560
[TBL] [Abstract][Full Text] [Related]
9. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
[TBL] [Abstract][Full Text] [Related]
10. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
[TBL] [Abstract][Full Text] [Related]
11. Atypical GH insensitivity syndrome and severe insulin-like growth factor-I deficiency resulting from compound heterozygous mutations of the GH receptor, including a novel frameshift mutation affecting the intracellular domain.
Aisenberg J; Auyeung V; Pedro HF; Sugalski R; Chartoff A; Rothenberg R; Derr MA; Hwa V; Rosenfeld RG
Horm Res Paediatr; 2010; 74(6):406-11. PubMed ID: 20606392
[TBL] [Abstract][Full Text] [Related]
12. Partial growth hormone insensitivity--idiopathic short stature is not always idiopathic.
Saenger P
Acta Paediatr Suppl; 1999 Feb; 88(428):194-8. PubMed ID: 10102079
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone/IGF-I axis and growth hormone receptor mutations in idiopathic short stature.
El Kholy M; Mella P; Rashad M; Buzi F; Meazza C; Zahra S; Elsedfy HH
Horm Res Paediatr; 2011; 76(5):300-6. PubMed ID: 21846964
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone insensitivity syndrome caused by a heterozygous GHR mutation: phenotypic variability owing to moderation by nonsense-mediated decay.
Gorbenko del Blanco D; de Graaff LC; Visser TJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2012 May; 76(5):706-12. PubMed ID: 22117696
[TBL] [Abstract][Full Text] [Related]
15. Serum growth hormone (GH) binding protein, IGF-I and IGFBP-3 in patients with beta-thalassaemia major and the effect of GH treatment.
Low LC; Postel-Vinay MC; Kwan EY; Cheung PT
Clin Endocrinol (Oxf); 1998 May; 48(5):641-6. PubMed ID: 9666877
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome).
Savage MO; Blum WF; Ranke MB; Postel-Vinay MC; Cotterill AM; Hall K; Chatelain PG; Preece MA; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Dec; 77(6):1465-71. PubMed ID: 7505286
[TBL] [Abstract][Full Text] [Related]
17. Review of Turkish patients with growth hormone insensitivity (Laron type).
Yordam N; Kandemir N; Erkul I; Kurdoğlu S; Hatun S
Eur J Endocrinol; 1995 Nov; 133(5):539-42. PubMed ID: 7581982
[TBL] [Abstract][Full Text] [Related]
18. Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype.
Azcona C; Preece MA; Rose SJ; Fraser N; Rappaport R; Ranke MB; Savage MO
Clin Endocrinol (Oxf); 1999 Dec; 51(6):787-92. PubMed ID: 10619985
[TBL] [Abstract][Full Text] [Related]
19. Primary GH insensitivity '(Laron syndrome) caused by a novel 4 kb deletion encompassing exon 5 of the GH receptor gene: effect of intermittent long-term treatment with recombinant human IGF-I.
Besson A; Salemi S; Eblé A; Joncourt F; Gallati S; Jorge AA; Mullis PE
Eur J Endocrinol; 2004 May; 150(5):635-42. PubMed ID: 15132718
[TBL] [Abstract][Full Text] [Related]
20. The first homozygous mutation (S226I) in the highly-conserved WSXWS-like motif of the GH receptor causing Laron syndrome: supression of GH secretion by GnRH analogue therapy not restored by dihydrotestosterone administration.
Jorge AA; Souza SC; Arnhold IJ; Mendonca BB
Clin Endocrinol (Oxf); 2004 Jan; 60(1):36-40. PubMed ID: 14678285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
